Study Issues

Use the resources in this section of AccrualNet™ to ensure that the protocol is written in a way that minimizes burden to both participants and staff.

Eligibility (149)

Image Representing Resource Type (Journal Article)
Posted: Jan 06, 2016.
J Natl Cancer Inst. 108. 2. djv324.
KEYWORDS: Eligibility, Randomization, Study Burden, Cancer, Treatment, Phase 0,1,2, Phase 3-4
Image Representing Resource Type (Journal Article)
Posted: Oct 06, 2015.
International Journal of Medical Informatics. 84. 1. 15-23.
KEYWORDS: Level of Clinical Trials Knowledge or Awareness, Institutional Issues, Eligibility, EMR, Non-Cancer, Cancer, Treatment

Placebo (31)

Image Representing Resource Type (Journal Article)
Posted: Jan 30, 2014.
AJOB Primary Research. 4. 4. 26-38.
KEYWORDS: Attitudes, Regulatory Issues, Eligibility, Placebo, Randomization, Provider Influence, Conflict of Interest
Image Representing Resource Type (Journal Article)
Posted: Sep 26, 2013.
PLoS One. 8. 7. e67352.
KEYWORDS: Knowledge/Attitudes/Beliefs, Provider-Patient Relationship, International, Placebo, Randomization, Consent, Provider Influence, Children, Verbal Communications, Non-Cancer, Treatment

Randomization (80)

Image Representing Resource Type (Journal Article)
Posted: Apr 03, 2017.
Support Care Cancer. 1-6. [Epub ahead of print]
KEYWORDS: Knowledge/Attitudes/Beliefs, Level of Clinical Trials Knowledge or Awareness, Randomization, Study Burden, Cancer, Treatment
Image Representing Resource Type (Journal Article)
Posted: Jan 06, 2016.
J Natl Cancer Inst. 108. 2. djv324.
KEYWORDS: Eligibility, Randomization, Study Burden, Cancer, Treatment, Phase 0,1,2, Phase 3-4

Study Burden (105)

Image Representing Resource Type (Journal Article)
Posted: Apr 03, 2017.
Support Care Cancer. 1-6. [Epub ahead of print]
KEYWORDS: Knowledge/Attitudes/Beliefs, Level of Clinical Trials Knowledge or Awareness, Randomization, Study Burden, Cancer, Treatment
Image Representing Resource Type (Journal Article)
Posted: Jan 06, 2016.
J Natl Cancer Inst. 108. 2. djv324.
KEYWORDS: Eligibility, Randomization, Study Burden, Cancer, Treatment, Phase 0,1,2, Phase 3-4